BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31841033)

  • 1. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
    Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
    Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
    Martins A; Gonçalves A; Almeida T; Midões A
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
    Fugazzola L
    Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
    [No Abstract]   [Full Text] [Related]  

  • 7. Medullary thyroid cancer with undetectable serum calcitonin.
    Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
    J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
    Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
    Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of medullary thyroid cancer in the prediction of cure after thyroidectomy.
    Nien FJ; Chang TC
    J Formos Med Assoc; 2015 Sep; 114(9):793-4. PubMed ID: 23906686
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic Challenges of Medullary Thyroid Carcinoma.
    Leimbach RD; Hoang TD; Shakir MKM
    Oncology; 2021; 99(7):422-432. PubMed ID: 33878761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
    Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
    Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
    Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
    Asarkar A; Chang BA; Nathan CO
    Laryngoscope; 2021 Mar; 131(3):458-459. PubMed ID: 32311764
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
    Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
    BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical challenges with calcitonin-negative medullary thyroid carcinoma: three case reports and a review of the literature.
    Jingzhu Z; Xiangqian Z; Ming G; Yi P; Jiadong C; Xinwei Y; Guangwei X
    Ann R Coll Surg Engl; 2022 Mar; 104(3):221-230. PubMed ID: 34767473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioguided hepatic resection with
    López-Gómez J; Medina-Ornelas S; Salazar-Álvarez MA; Álvarez-Bojórquez M; Zaragoza-Cruz N; Melchor-Ruan J; Álvarez-Cano A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):244-249. PubMed ID: 29754940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.